LPM6690176

DRUG2 trials

Sponsors

Luye Pharma Group Ltd.

Conditions

Advanced Solid TumorMetastatic Colorectal Cancer (mCRC)

Phase 1

First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.

RecruitingNCT06240546

Luye Pharma Group Ltd.Advanced Solid Tumor

Start: 2024-03-12End: 2027-02-28Target: 102Updated: 2024-03-15

LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation

Not yet recruitingNCT07391566

Luye Pharma Group Ltd.Metastatic Colorectal Cancer (mCRC)

Start: 2026-03-31End: 2028-12-31Target: 99Updated: 2026-02-06